← Open Payments lookup

LASZLO TRAZKOVICH: Open Payments

NPI 1528080025 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$441 in 20 payments from 9 companies in 2025. Trend: 2023 $420 · 2024 $228 · 2025 $441

Food & beverage: $441
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$94
Teva Pharmaceuticals USA, Inc.3$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$58
Otsuka America Pharmaceutical, Inc.3$57
Lundbeck LLC2$51
Alkermes, Inc.2$49
Supernus Pharmaceuticals, Inc.2$34
E.R. Squibb & Sons, L.L.C.1$24
Axsome Therapeutics, Inc.1$17

Products named: INGREZZA, UZEDY, CAPLYTA, REXULTI, ARISTADA, ABILIFY MAINTENA, Qelbree, COBENFY.

Industry payments across MD — which companies pay providers there.